European Journal of Cancer
Volume 39, Issue 7 , Pages 870-880 , May 2003

Geriatric oncology: a clinical approach to the older patient with cancer

  • L. Repetto

      Affiliations

    • U.O. Oncologia Istituto Nazionale di Riposo e Cura per Anziani (INRCA), Via Cassia 1167, 00189 Rome, Italy
    • Corresponding Author InformationCorresponding author
    • ,
  • A. Venturino

      Affiliations

    • U.O. Oncologia Medica USL 1 Imperiese, San Remo, Italy
    • ,
  • L. Fratino

      Affiliations

    • Divisione di Oncologia Medica Azienda Ospedale Università, Padova, Italy
    • ,
  • D. Serraino

      Affiliations

    • Istituto Nazionale per le Malattie Infettive L. Spallanzani, Rome, Italy
    • ,
  • G. Troisi

      Affiliations

    • Dipartimento Scienze dell'Invecchiamento Università La Sapienza, Rome, Italy
    • ,
  • W. Gianni

      Affiliations

    • U.O. Oncologia Istituto Nazionale di Riposo e Cura per Anziani (INRCA), Via Cassia 1167, 00189 Rome, Italy
    • ,
  • M. Pietropaolo

      Affiliations

    • Dipartimento Scienze dell'Invecchiamento Università La Sapienza, Rome, Italy

Received 17 December 2002 ,Accepted 6 January 2003.

References 

  1. World Health Organization (WHO). World Health Statistics Annual. Geneva: WHO; 1987;
  2. Murray CJL, Lopez Ad. Alternative projections of mortality and disability by cause 1990–2020 (global burden of disease study). Lancet. 1997;349:1498–1504
  3. Yancik R, Ries LAG. Aging and cancer in America (demographic and epidemiologic perspectives). Hematol/Oncol Clin, North Am. 2000;14:17–23
  4. Yancik RM, Ries L. Cancer and age (magnitude of the problem). In:  Balducci L,  Lyman GH,  Ershler WB editor. Comprehensive Geriatric Oncology. 2nd edn. London: Harwood Academic; 1998;p. 95–103
  5. Franceschi S, La Vecchia C. Cancer epidemiology in the elderly. Crit. Rev. Oncol. Hematol. 2001;39:219–226
  6. Negri E, La Vecchia C, Decarli A. Cancer mortality in Italy. Tumori. 2002;88:89–94
  7. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents, vol. VII. IARC Sci Publication No. 143. Lyon: IARC; 1997;
  8. Armitage P, Doll R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br. J. Cancer. 1961;11:161–169
  9. Stanta G, Campagner L, Cavallieri F, Giarelli L. Cancer of the oldest old (what we have learned from autopsy studies). Clin. Ger. Med. 1997;13:55–68
  10. Peto R, Parish SE, Gray RG. There is no such thing as ageing, and cancer is not related to it. In Likhacev A, Anisimov V, Montesano R, eds. Age-related Factors in Carcinogenesis: Proceedings of a Symposium. Lyon, IARC, 1985, 45–53.
  11. Balducci L, Extermann M. Cancer and aging. An evolving panorama. Hematol. Oncol. Clin. North Am. 2000;14:1–16
  12. Vercelli M, Quaglia A, Casella C, Parodi S, Capocaccia R, Martinez Garcia C. Relative survival in elderly cancer patients in Europe. EUROCARE Work Group. Eur. J. Cancer. 1998;34:2264–2270
  13. Balducci L, Lyman GH. Cancer in the elderly (epidemiologic and clinical implications). Clin. Geriatr. Med. 1997;13:1–14
  14. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C. Changed trends of cancer mortality in the elderly. Ann. Oncol. 2001;12:1467–1477
  15. Begg CB, Cohen JL, Ellerton J. Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group. Clin. Trials. 1980;3:369–374
  16. Kemeny M, Muss HB, Kornblith AB, Peterson B, Wheeler J, Cohen HJ. Barriers to participation of older women with breast cancer in clinical trials. Proc. Am. Soc. Clin. Oncol. 2000;19:2371
  17. Maly RC. Qualitative research for the study of cancer and age. Hematol. Oncol. Clin. North Am. 2000;14:79–88
  18. Schmidt K. Physiology and pathophysiology of senescence. Int. J. Vitam. Nutr. Res. 1999;69:150–153
  19. Glass AG, Hoover RN. The emerging epidemics of melanoma and squamous cell skin cancer. J. Am. Med. Ass. 1989;262:2097–2100
  20. Balducci L, Pow-Sang J, Friedland J, Diaz JI. Prostate cancer. Clin. Ger. Med. 1997;13:283–307
  21. Anisimov VN, Gvardina OE. N-Nitrosomethylurea-induced carcinogenesis in the progeny of male rats of different ages. Mutat. Res. 1995;316:139–145
  22. Randerath K, Liehr JG, Gladeck A, Randerath E. Age-dependent covalent DNA alteration (I compounds) in rodent tissues (species, tissue and sex specifications). Mutat. Res. 1989;219:121–133
  23. Collins K. Mammalian telomeres and telomerase. Curr. Opin. Cell Biol. 2000;12:378–383
  24. Liggett WH, Sidransky D. Role of the P16 tumor suppressor gene in cancer. J. Clin. Oncol. 1998;16:1197–1206
  25. Anisimov VN. Age as a risk factor in multistage carcinogenesis. In:  Balducci L,  Lyman GH,  Ershler WB editor. Comprehensive Geriatric Oncology. Amsterdam: Harwood Academic; 1998;p. 157–178
  26. Kraupp-Grasl B, Huber W, Taper H, Schulte-Hermann R. Increased susceptibility of aged rats to hepatocarcinogenesis induced by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occuring spontaneously. Cancer Res. 1991;51:666–671
  27. Ebbesen P. Papilloma development on young and senescent mouse skin treated with 12-tetradecanoylforbol-13-acetate. In:  Likhacev A,  Anisimov V,  Montesano R, et al. editor. Age-related Factors in Carcinogenesis. IARC Scientific Publication No. 58. Lyon, France: IARC; 1985;p. 167–170
  28. Barbone F, Bovenzi M, Cavallieri F, Stanta G. Air pollution and lung cancer in Trieste, Italy. Am. J. Epidemiol. 1995;141:1161–1169
  29. Monfardini S, Carbone A. Non-Hodgkin's lymphomas. In:  Balducci L,  Lyman GH,  Ershler WB editor. Comprehensive Geriatric Oncology. Amsterdam: Harwood Academic; 1998;p. 577–595
  30. Flowers A. Brain tumors. In:  Balducci L,  Lyman GH,  Ershler WB editor. Comprehensive Geriatric Oncology. Amsterdam: Harwood Academic; 1998;p. 703–720
  31. Balducci L. Geriatric Oncology (challenges for the new century). Eur. J. Cancer. 2000;36:1741–1754
  32. Goodwin J, Burns E. Immunological changes of aging. In:  Balducci L,  Lyman GH,  Ershler WB editor. Comprehensive Geriatric Oncology. Amsterdam: Harwood Academic; 1998;p. 213–222
  33. Bonafè M, Valesin S, Gianni W, Marigliano W, Franceschi C. The unexpected contribution of immunosenescence to the levelling off of cancer incidence and mortality in the oldest old. Crit. Rev. Oncol. Hematol. 2001;39:227–233
  34. Campisi J. Cancer and age (the double sword of proliferative senescence). J. Am. Ger. Soc. 1997;45:482–488
  35. Warner HR. Aging and regulation of apoptosis. Curr. Top. Cell Regul. 1997;35:107–121
  36. Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals (the lesson of centenarians). Immunol. Today. 1995;16:12–16
  37. Lancet JE, Willman CL, Bennett JM. Acute myelogenous leukemia and aging (clinical interactions). Hematol. Oncol. Clinics. North Am. 2000;16:251–268
  38. The International Non-Hodgkin's Lymphoma prognostic factors project: a predictive model for aggressive non-hodgkin's lymphoma. N Engl J Med 1993, 329, 87–94.
  39. Thigpen JT. Gynecologic cancer. In:  Balducci L,  Lyman GH,  Ershler WB editor. Comprehensive Geriatric Oncology. Amsterdam: Harwood Academic; 1998;p. 721–732
  40. Ershler WB. Tumor-host interactions, aging and tumor growth. In:  Balducci L,  Lyman GH,  Ershler WB editor. Comprehensive Geriatric Oncology. Amsterdam: Harwood Academic; 1998;p. 201–211
  41. Willman CL. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukaemia (studies of the Southwest Oncology Group Leukemia Research programm). Semin. Hematol. 1997;34:25–36
  42. Hamermann D, Berman JW, Albers GW, Brown DL, Silver D. Emerging evidence for inflammation in conditions frequently affecting older adults (report of a symposium). J. Am. Ger. Soc. 1999;47:995–999
  43. Preti HJ, Cabanillas F, Talpaz M, Jucker SL, Seymour JF, Kurzrock R. Prognostic value of serum interleukin-6 in diffuse large cell lymphoma. Ann. Intern. Med. 1997;127:186–194
  44. Balducci L, Silliman RA, Diaz N. Breast cancer: an oncological perspective. In Balducci L, Lyman GH, Ershler WB, eds. Comprehensive Geriatric Oncology, 2nd ed. London, Harwood Academic (in press).
  45. Hamermann D. Toward an understanding of frailty. Ann. Intern. Med. 1999;130:945–950
  46. Cohen HJ, Pieper CF, Harris T. Markers of inflammation and coagulation predict decline in function and mortality in community dwelling elderly. Proc. Am. Ger. Soc. 2001;S1: (abstr A3).
  47. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 2001;8:131–136
  48. Kushner I. C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging. Cleve. Clin. J. Med. 2001;68:535–537
  49. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons (MacArthur studies of successful aging). J. Gerontol. A Biol. Sci. Med. Sci. 2000;55:M709–M715
  50. Balducci L. The comprehensive geriatric assessment in the management of the older person with cancer. Eur J Gerontol (in press).
  51. Craig Rubin D, Sizemore T, Loftis PA, Loret de Nola N. A randomized, controlled trial of outpatient geriatric evaluation and management in a large public hospital. J. Am. Ger. Soc. 1993;41:1023–1028
  52. Stuck AE, Aronow HU, Steiner A, et al.  A trial of annual in-home comprehensive geriatric assessment for elderly people living in the community. N. Engl. J. Med. 1995;333:1184–1189
  53. Christensen K. Why do we age so differently?. Lakartidningen. 1999;96:5099–5102
  54. Fratiglioni L, Von Strauss E, Winblad B. Epidemiology of aging with focus on physical and mental functional ability. Lakartidningen. 2001;98:552–558
  55. MacKnight C, Rockwood K. Use of chronic disease score to measure comorbidity in the Canadian Study of Health and Aging. Int. Psychogeriatr. 2001;13:37–142
  56. Charlson ME, Pompei P, Ales K, Mackenzie CR. A new method of classifying comorbidity in longitudinal studies (development and validation). J. Chronic. Dis. 1987;40:373–383
  57. Miller MD, Paradis CF, Houck PR, et al.  Rating chronic medical illness burden in geropsychiatric practice and research (application of the cumulative illness rating scale). Psychiatric. Res. 1992;41:237–248
  58. Nikolaus T. Effect of physical activity on functional performance. Z. Gerontol. Geriatr. 2001;34:44–47
  59. Leveille SG, Guralnik JM, Ferrucci L, Langlois JA. Aging successfully until death in old age (opportunities for increasing active life expectancy). Am. J. Epidemiol. 1999;149:654–664
  60. Pientka L. Knowledge for prolonging longevity without disability. Z. Gerontol. Geriatr. 2001;34:38–43
  61. Dartigues JF, Fabrigoule C, Barberger-Gateau P, Orgogozo JM. emory, aging and risk factors. Lessons from clinical trials and epidemiologic studies. Therapie. 2000;55:503–505
  62. Unger JB, McAvay G, Bruce ML, Berkman L, Seeman T. Variation in the impact of social network characteristics on physical functioning in elderly persons (MacArthur Studies of Successful Aging). J. Gerontol. B Psychol. Sci. Soc. Sci. 1999;54:S245–S251
  63. Weitzner MA, Haley WE, Chen H. The family caregiver of the older cancer patient. Hematol. Oncol. Clin. 2000;14:269–282
  64. Haley WE, Ehrbar L, Schonwetter RS. Family caregiving issues. In:  Balducci L,  Lyman GH,  Ershler WB editor. Comprehensive Geriatric Oncology. London: Harwood Academic; 1998;p. 805–812
  65. Hayman JA, Langa KM, Kabeto MU, et al.  Estimating the cost of informal caregiving for elderly patients with cancer. J. Clin. Oncol. 2001;19:3219–3225
  66. Balducci L, Extermann M. A practical approach to the older patient with cancer. Current problems. Cancer. 2001;25:1–76
  67. Guigoz Y, Vellas B, Garry PJ. Mininutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients. In Guigoz Y, Vellas B, Garry PJ, eds. Facts, Research, Interventions in Geriatrics, 1997. New York, Serdi, 1997, 15–60.
  68. Corcoran MB. Polypharmacy in the older patient. In:  Balducci L,  Lyman GH,  Ershler WB editor. Comprehensive Geriatric Oncology. London: Harwood Academic; 1998;p. 525–532
  69. Meydani M. Nutrition interventions in aging and age-associated disease. Ann. N. Y. Acad. Sci. 2001;928:226–235
  70. Fox RA, Pxty J. Geriatric and the Problem Solving Approach. Medicine in the Frail Elderly: A Problem Oriented Approach. London: Arnold; 1993; 1–13
  71. Guralnik JM, LaCroix AZ, Everett DF, Kovar MG. Aging in the Eighties: The Prevalence of Comorbidity and Its Association with Disability. Advance Data from Vital and Health Statistical 1989, No. 170. National Center of Health Statistic, Bethesda, USA.
  72. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10:20–30
  73. Lawton MP, Brody E. Assessment of older people (self-maintaining and instrumental activities of daily living). Gerontologist. 1969;9:179–186
  74. Fratino L, Ferrario L, Redmond K, Audisio RA. Global Health care (the role of geriatrician, general practitioner and oncology nurse). Crit. Rev. Oncol. Hematol. 1998;27:101–109
  75. Matthews DA. Marjory Warren and the origin of British geriatrics. J. Am. Geriatr. Soc. 1984;32:253–258
  76. Hendriksen C, Lund E, Stremgard E. Consequences of assessment and intervention among elderly people (a 3 year randomised controlled trial). Br. Med. J. 1984;289:1522–1524
  77. Stuck AK, Siu AL, Wieland DG, Adams J, Rubenstein LZ. Comprehensive geriatric assessment. A meta-analysis of controlled trials. Lancet. 1993;342:1032–1036
  78. Working Group of the Royal College of Physicians and the British Geriatric Society. Standardised Assessment Scales for Elderly People. London: Royal College of Physicians; 1992;
  79. Health and Public Policy Committee. American College of Physicians. Comprehensive geriatric assessment for elderly patients. position paper. Ann. Intern. Med. 1988;1:70–73
  80. Applegate WB, Miller ST, Graney MJ, Elam JT, Burns R, Akins DE. A randomised controlled trial of geriatric assessment unit in a community rehabilitation hospital. New Engl. J. Med. 1990;322:1572–1578
  81. Bernabei R, Landi F, Gambassi G, et al.  Randomised trial of impact of model of integrated care and case management for older people living in the community. Br. Med. J. 1998;316:1348–1351
  82. Alessi CA, Stuck AE, Aronow HU, et al.  The process of care in preventive “in home” comprehensive geriatric assessment. J. Am. Ger. Soc. 1997;45:1044–1050
  83. Tinetti ME, Baker DI, McAvay G, Claus EB, Garret P, Gottschalk M. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N. Engl. J. Med. 1994;331:821–827
  84. Inouye SK, Bogardus ST, Charpentier PA, et al.  A multicomponent intervention to prevent delirium in hospitalized older patients. N. Engl. J. Med. 1999;340:669–676
  85. Reuben DB, Franck JC, Hirsch SH, McGuigan KA, Maly RC. A randomized clinical trial of outpatient geriatric assessment (CGA), coupled with an intervention, to increase adherence to recommendations. J. Am. Ger. Soc. 1999;47:269–276
  86. Fried LP, Walston J. Frailty and failure to thrive. In:  Hazzard WR,  Blass JP,  Ettinger WH,  Halter JB,  Ouslander JG editor. Principle of Geriatric Medicine and Gerontology. 4th ed.. New York: McGraw Hill; 1999;p. 1387–1402
  87. Rockwood K, Fox RA, Stolee P. Frailty in elderly people (an evolving concept). Can. Med. Assoc. J. 1994;150:489–495
  88. Campbell AJ, Buchner DM. Unstable disability and the fluctuations of frailty. Age Ageing. 1997;26:315–318
  89. Ferrucci L, Harris TB, Guralnik JM, et al.  Serum IL-6 and the development of disability in older persons. J. Am. Geriatr. Soc. 1999;47:639–646
  90. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999;283:1482–1488
  91. Morley JE, Kaiser FE, Sih R, Hajjar R, Perry 3rd HM. Testosterone and frailty. Clin. Geriatr. Med. 1997;13:685–695
  92. Ranieri P, Rozzini R, Franzoni S, Barbisoni P, Trabucchi M. Serum cholesterol levels as measure of frailty in elderly patients. Exp. Aging Res. 1998;24:169–179
  93. Fried LP, Tangen C, Walston J, et al.  Frailty on older adults (evidence for a phenotype). J. Gerontol. Med. Sci. 2001;56:M146–M156
  94. Rockwood K, Stadnyk K, Macknight C, McDowell I, Hebert R, Hogan DB. A brief clinical instrument to classify frailty in elderly people. Lancet. 1999;353:205–206
  95. Balducci L, Stanta G. Cancer in the frail patient (a coming epidemic). Hematol. Oncol. Clin. North Am. 2000;14:235–250
  96. Repetto L, Comandini D. Cancer in the elderly (assessing patients for fitness). Crit. Rev. Oncol. Hematol. 2000;35:155–160
  97. Exterman M, Aapro M. Assessment of the older cancer patient. Hematol. Oncol. Clin. North Am. 2000;14:63–77
  98. Monfardini S, Ferrucci L, Fratino L, Del Lungo I, Serraino D, Zagonel V. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer. 1996;77:395–401
  99. Repetto L, Fratino L, Audisio RA, et al.  The Comprehensive Geriatric Assessment adds information to ECOG Performance Status in elderly cancer patients (a GIOGer study). J. Clin. Oncol. 2002;20:494–502
  100. Bennet JM, Sahasrabudhe DM, Hall WJ. Medical oncology and geriatric medicine it is time to fellowship integration. Ann. Oncol. 1998;9:S16–S18
  101. Balducci L, Beghè C. The application of the principles of geriatrics to the management of the older person with cancer. Crit. Rev. Oncol. Hematol. 2000;35:147–154
  102. Reuben DB, Rubenstein LV, Hirsch SH, Hays RD. Value of functional status as predictor of mortality. Am. J. Med. 1992;93:663–669
  103. Inoyue SK, Peduzzi PN, Robison JT, Hughes JS, Horwitz RI, Concato J. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA. 1998;279:1187–1193
  104. Siu AL, Moshita L, Blaustein J. Comprehensive geriatric assessment in a day hospital. J. Am. Ger. Soc. 1994;42:1094–1099
  105. Barbeger-Gateau P, Fabrigoule C, Helmer C, Rouch I, Dartigues JF. Functional impairment in instrumental activities of daily living (an early clinical sign of dementia?). J. Am. Ger. Soc. 1999;47:456–462
  106. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann. Int. Med. 1994;120:104–110
  107. Piccirillo JF, Feinstein AR. Clinical symptoms and comorbidity (significance for the prognostic classification of cancer). Cancer. 1996;77:834–842
  108. Manton K. A longitudinal study of functional change and mortality in the United States. J. Gerontol. 1988;43:S153–S161
  109. Eagles JM, Beattie JAG, Restall DB, Rawlinson F, Hagen S, Ashcroft GW. Relationship between cognitive impairment and early death in the elderly. Br. Med. J. 1990;300:239–240
  110. Bruce ML, Hoff RA, Jacobs SC, Leaf PJ. The effect of cognitive impairment on 9-year mortality in a community sample. J. Gerontol. 1995;50:P289–P296
  111. Folstein ME, Folstein SE, McHugh PR. A mini mental state (a practical method for grading the cognitive status of patients for the clinician). J. Psychiatr. Res. 1975;12:189–198
  112. Covinsky KE, Kahana E, Chin MH, Palmer RM, Fortinsky RH, Landefeld CS. Depressive symptoms and three year mortality in older hospitalized medical patients. Ann. Int. Med. 1999;130:563–569
  113. Lyness JM, King DA, Cox C, Yoedino Z, Caine ED. The importance of subsyndromal depression in older primary care patients. Prevalence and associated functional disability. J. Am. Ger. Soc. 1999;47:647–652
  114. Kimmick GG, Muss HB. Systemic therapy for older women with breast cancer. Oncology (Huntingt.). 2001;15:280–291 [discussion 291–292, 295–296, 299].
  115. Repetto L, Venturino A, Vercelli M, et al.  Performance status and comorbidity in elderly cancer patients compared to a young neoplastic and an elderly non-neoplastic population. Cancer. 1998;82:760–765
  116. Satoh H, Ishikawa H, Funayama Y, et al.  Management of small cell lung cancer in elderly. Anticancer Res. 1999;19:4507–4510
  117. Ashkanani F, Eremin O, Heys SD. The management of cancer of the breast in the elderly. Eur. J. Surg. Oncol. 1998;24:396–402
  118. Muss HB. Breast cancer in older women. Semin. Oncol. 1996;23(Suppl. 2):S82–S88
  119. Kennedy BJ. Cancer research and the aging population. Oncol. Issues. 2000;15:20–28
  120. Goodwin JS, Hunt WC, Samet JM. Determinants of cancer therapy in elderly patients. Cancer. 1993;72:594–601
  121. Goodwin JS, Samet JM, Key CR, Humble C, Kutvirt D, Hunt C. Stage at diagnosis of cancer varies with the age of the patient. J. Am. Geriatr. Soc. 1986;34:20–26
  122. Johnson DH. Small cell lung cancer in the elderly patient. Semin. Oncol. 1997;24:484–491
  123. Monfardini S, Sorio R, Kaye S. Should elderly cancer patients be entered in dose-escalation studies?. Ann. Oncol. 1994;5:964–966

PII: S0959-8049(03)00062-5

doi: 10.1016/S0959-8049(03)00062-5

European Journal of Cancer
Volume 39, Issue 7 , Pages 870-880 , May 2003

Article Tools